相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Determination of mRNA Expression of Human UDP-Glucuronosyltransferases and Application for Localization in Various Human Tissues by Real-Time Reverse Transcriptase-Polymerase Chain Reaction
Shuji Ohno et al.
DRUG METABOLISM AND DISPOSITION (2009)
In vitro characterisation of human renal and hepatic frusemide glucuronidation and identification of the UDP-glucuronosyltransferase enzymes involved in this pathway
Oranun Kerdpin et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines
Akiko Nakamura et al.
DRUG METABOLISM AND DISPOSITION (2008)
The Albumin Effect and drug glucuronidation: Bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities
Andrew Rowland et al.
DRUG METABOLISM AND DISPOSITION (2008)
The Configuration of the 17-Hydroxy Group Variably Influences the Glucuronidation of β-Estradiol and Epiestradiol by Human UDP-Glucuronosyltransferases
Katriina Itaaho et al.
DRUG METABOLISM AND DISPOSITION (2008)
Novel polymorphic human UDP-glucuronosyltransferase 2A3: Cloning, functional characterization of enzyme variants, comparative tissue expression, and gene induction
Michael H. Court et al.
MOLECULAR PHARMACOLOGY (2008)
Contribution of UDP-glucuronosyltransferase 1A1 and 1A8 to morphine-6-glucuronidation and its kinetic properties
Shuji Ohno et al.
DRUG METABOLISM AND DISPOSITION (2008)
Human renal cortical and medullary UDP-Glucuronosyltransferases (UGTs): Immunohistochemical localization of UGT2B7 and UGT1A enzymes and kinetic characterization of S-Naproxen glucuronidation
Paraskevi Gaganis et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Glucuronidation of fenamates: Kinetic studies using human kidney cortical microsomes and recombinant UDP-glucuronosyltransferase (UGT) 1A9 and ZB7
Paraskevi Gaganis et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Binding of inhibitory fatty acids is responsible for the enhancement of UDP-glucuronosyltransferase 2B7 activity by albumin: Implications for in vitro-in vivo extrapolation
Andrew Rowland et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Identification of human UDP-glucuronosyltransferase isoform(s) responsible for the C-glucuronidation of phenylbutazone
Takahito Nishiyama et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2006)
Identification of human UDP-glucuronosyltransferase responsible for the glucuronidation of niflumic acid in human liver
Yuji Mano et al.
PHARMACEUTICAL RESEARCH (2006)
In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: Pitfalls and promises
JO Miners et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Kinetics of acetaminophen glucuronidation by UDP-glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential implications in acetaminophen-induced hepatotoxicity
AE Mutlib et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2006)
Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data:: the effect of fluconazole on zidovudine glucuronidation
V Uchaipichat et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Cyclooxygenase: Past, present and future. A tribute to John R. Vane (1927-2004)
RM Botting
JOURNAL OF THERMAL BIOLOGY (2006)
S-Naproxen and desmethylnaproxen glucuronidation by human liver microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT2B7 in the elimination of naproxen
K Bowalgaha et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily
PI Mackenzie et al.
PHARMACOGENETICS AND GENOMICS (2005)
Kidneys contribute to the extrahepatic clearance of propofol in humans, but not lungs and brain
H Hiraoka et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism
N Picard et al.
DRUG METABOLISM AND DISPOSITION (2005)
Glucuronidation of carboxylic acid containing compounds by UDP-glucuronosyltransferase isoforms
K Sakaguchi et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2004)
Human UDP-glucuronosyltransferases: Isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid
V Uchaipichat et al.
DRUG METABOLISM AND DISPOSITION (2004)
Cyclooxygenase isozymes: The biology of prostaglandin synthesis and inhibition
DL Simmons et al.
PHARMACOLOGICAL REVIEWS (2004)
Glucuronidation of oxidized fatty acids and prostaglandins B1 and E2 by human hepatic and recombinant MP-glucuronosyftransferases
JM Little et al.
JOURNAL OF LIPID RESEARCH (2004)
The main role of UGT1A9 in the hepatic metabolism of mycophenolic acid and the effects of naturally occurring variants
O Bernard et al.
DRUG METABOLISM AND DISPOSITION (2004)
N-glucuronidation of carbamazepine in human tissues is mediated by UGT2B7
AG Staines et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7
P Tsoutsikos et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Specificity and regioselectivity of the conjugation of estradiol, estrone, and their catecholestrogen and methoxyestrogen metabolites by human uridine diphospho-glucuronosyltransferases expressed in endometrium
J Lépine et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Isoform selectivity and kinetics of morphine 3-and 6-glucuronidation by human UDP-glucuronosyltransferases: Evidence for atypical glucuronidation kinetics by UGT2B7
AN Stone et al.
DRUG METABOLISM AND DISPOSITION (2003)
Evaluation of 3′-azido-3′-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes:: Specificity and influence of the UGT2B7*2 polymorphism
MH Court et al.
DRUG METABOLISM AND DISPOSITION (2003)
Urinary metabolites of leukotriene B4 in the human subject
KAZ Berry et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Glucuronidation of arachidonic and linoleic acid metabolites by human UDP-glucuronosyltransferases
D Turgeon et al.
JOURNAL OF LIPID RESEARCH (2003)
Human uridine diphosphate-glucuronosyltransferase UGT2B7 conjugates mineralocorticoid and glucocorticoid metabolites
C Girard et al.
ENDOCRINOLOGY (2003)
Adverse renal effects of anti-inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors
G Gambaro et al.
JOURNAL OF INTERNAL MEDICINE (2003)
Almokalant glucuronidation in human liver and kidney microsomes: evidence for the involvement of UGT1A9 and 2B7
BK Gaiser et al.
XENOBIOTICA (2003)
In vitro analysis of human drug glucuronidation and prediction of in vivo metabolic clearance
MG Soars et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Nuclear UDP-glucuronosyltransferases: Identification of UGT2B7 and UGT1A6 in human liver nuclear membranes
A Radominska-Pandya et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2002)
Role of eicosanoids in prostate cancer progression
DT Nie et al.
CANCER AND METASTASIS REVIEWS (2001)
Prostaglandins and leukotrienes: Advances in eicosanoid biology
CD Funk
SCIENCE (2001)
The glucuronidation of mycophenolic acid by human liver, kidney and jejunum microsomes
K Bowalgaha et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Glucuronidation of linoleic acid diols by human microsomal and recombinant UDP-glucuronosyltransferases: Identification of UGT2B7 as the major isoform involved
AR Jude et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2001)
Characterization of biotransformation enzyme activities in primary rat proximal tubular cells
GJ Schaaf et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2001)
Analysis of the toxic effects of linoleic acid, 12,13-cis-epoxyoctadecenoic acid, and 12,13-dihydroxyoctadecenoic acid in rabbit renal cortical mitochondria
JH Moran et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2001)
Mycophenolic acid glucuronidation and its inhibition by non-steroidal anti-inflammatory drugs in human liver and kidney
M Vietri et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Tissue distribution and interindividual variation in human UDP-glucuronosyltransferase activity: relationship between UGT1A1 promoter genotype and variability in a liver bank
MB Fisher et al.
PHARMACOGENETICS (2000)
Linoleic acid diols are novel substrates for human UDP-glucuronosyltransferases
AR Jude et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2000)
Identification of uridine diphosphate glucuronosyltransferases involved in the metabolism and clearance of mycophenolic acid
PI Mackenzie
THERAPEUTIC DRUG MONITORING (2000)
分享论文
